EI
NVAX icon

Ellevest Inc’s Novavax NVAX Stock Holding History

Ellevest Inc’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-26
Closed -$2K – 1591
2022
Q1 		$2K Sell
26
-121
-82% -$10.8K ﹤0.01% 1210
2021
Q4 		$21K Buy
147
+136
+1,236% +$23.4K ﹤0.01% 710
2021
Q3 		$2K Buy
+11
New +$2.42K ﹤0.01% 1158
2021
Q2 		– Sell
-8
Closed -$1K – 1365
2021
Q1 		$1K Buy
+8
New +$1.59K ﹤0.01% 1179
2020
Q4 		– Sell
-21
Closed -$2K – 1301
2020
Q3 		$2K Buy
21
+14
+200% +$1.71K ﹤0.01% 920
2020
Q2 		$1K Hold
7
– – ﹤0.01% 1032
2020
Q1 		$0 Buy
+7
New +$59 ﹤0.01% 1236

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ellevest Inc's NVAX Position: Q2 2022 in Review

Ellevest Inc sold out of Novavax (NVAX) in Q2 2022, closing a stake of 26 shares — an estimated $2K sold.

Ellevest Inc first reported a position in NVAX in Q1 2020 and held it in 7 quarters. The position peaked at $21K in Q4 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Ellevest Inc reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Ellevest Inc sold 26 Novavax shares in Q2 2022, an estimated $2K.
  • Ellevest Inc first reported a position in Novavax in Q1 2020 and held it in 7 quarters.
  • Ellevest Inc's Novavax position peaked at $21K in Q4 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Ellevest Inc's 13F filing for Q2 2022, filed 18 Jul 2022.